STOCK TITAN

CEL-SCI (NYSE: CVM) awards Cipriano 80K options vesting over 3 years

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CEL-SCI Corp reported that Senior Vice President John Cipriano received a grant of 80,000 stock options on 2026-08-14. The options have an exercise price of $1.49 per share, a stated value of $0.01 per option, and expire on 2036-08-13. Following this grant, Cipriano holds 118,010 options directly. According to the grant terms, the options vest in three equal annual installments starting one year after the grant date.

Positive

  • None.

Negative

  • None.
Insider CIPRIANO JOHN
Role Senior Vice President
Type Security Shares Price Value
Grant/Award Options F1 80,000 $0.01 $800.00
Holdings After Transaction: Options — 118,010 shares (Direct)
Footnotes (1)
  1. F1. The stock options vest in three (3) equal annual installments commencing one year after the grant date.
Options granted 80,000 options Grant of stock options on 2026-08-14
Exercise price $1.49 per share Exercise price of newly granted options
Option grant value field $0.01 per option Reported transaction price per option in Form 4
Options after transaction 118,010 options Total options held by John Cipriano following the grant
Underlying shares 80,000 shares Common stock underlying the newly granted options
Option expiration date 2036-08-13 Expiration of the newly granted options
Vesting schedule 3 equal annual installments Vesting begins one year after the grant date
stock options financial
"The stock options vest in three (3) equal annual installments"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"conversion_or_exercise_price": "1.4900""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The stock options vest in three (3) equal annual installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

What insider transaction did CEL SCI CORP (CVM) report for John Cipriano?

CEL-SCI reported that Senior Vice President John Cipriano received a grant of 80,000 stock options on 2026-08-14. These options relate to CEL-SCI common stock and represent a compensation-related award rather than an open-market purchase or sale.

What is the exercise price of the new stock options granted to John Cipriano at CVM?

The newly granted options to John Cipriano have an exercise price of $1.49 per share. This is the price at which he may buy CEL-SCI common stock under the option terms before the options expire on 2036-08-13.

How many CEL SCI CORP (CVM) options does John Cipriano hold after this Form 4 transaction?

After the reported grant, John Cipriano directly holds 118,010 stock options. This total includes the newly granted 80,000 options and reflects his updated option position as disclosed in the Form 4 insider filing.

When do John Cipriano’s new CEL SCI CORP (CVM) stock options vest?

The 80,000 stock options granted to John Cipriano vest in three equal annual installments beginning one year after the grant date. This means one-third vests each year over three years, subject to the award’s continued-service conditions.

What is the expiration date of the stock options granted to John Cipriano by CEL SCI CORP (CVM)?

The stock options granted to John Cipriano expire on 2036-08-13. He may exercise vested options any time before that expiration date, in accordance with the plan and award agreement terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
CIPRIANO JOHN

(Last)(First)(Middle)
8229 BOONE BLVD
SUITE 802

(Street)
VIENNA VIRGINIA 22182

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Senior Vice President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Options$1.4908/14/2026A80,000 (1)08/13/2036Common Stock80,000$0.01118,010D
Explanation of Responses:
1. The stock options vest in three (3) equal annual installments commencing one year after the grant date.
John Cipriano08/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)